In 2017, Indivior PLC received the U.S. Food and Drug Administration (FDA) approval for its new SUBLOCADE (buprenorphine extended- release) injection for subcutaneous use. SUBLOCADE is indicated for the treatment of moderate to severe opioid use disorder.  In 2016, Teva Pharmaceutical Industries Ltd. launched a generic version of CAMPRAL1 (acamprosate calcium) delayed-release tablets, 333 mg in the U.S. market. This tablet is indicated for the treatment and maintenance of abstinence from ... Read more

Drug Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Alcohol, tobacco, cigarettes, heroin, and marijuana are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for treatment and management of drug abuse. Some commonly used drug for treatment of drugs abuse are Disulfiram, Acamprosate, Naltrexone, Nicotine Replacement Treatment, Methadone, and ... Read more